AZN vs TLYS · P/E 28, $288.38B cap vs rev $288.2M
AstraZeneca PLC (AZN) versus Tillys Inc (TLYS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Tillys Inc (TLYS) is a apparel retail company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported TLYS revenue for 2026-08-01 was $288.2M. Net income was $428.0K. TLYS currently screens at market cap $139.0M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. TLYS currently screens at market cap $139.0M.
Not investment advice. Open the AZN and TLYS stock pages for the full models.
Not investment advice.